• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

泛癌 T 细胞图谱将细胞应激反应状态与免疫治疗耐药性联系起来。

Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance.

机构信息

Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

出版信息

Nat Med. 2023 Jun;29(6):1550-1562. doi: 10.1038/s41591-023-02371-y. Epub 2023 May 29.

DOI:10.1038/s41591-023-02371-y
PMID:
37248301
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11421770/
Abstract

Tumor-infiltrating T cells offer a promising avenue for cancer treatment, yet their states remain to be fully characterized. Here we present a single-cell atlas of T cells from 308,048 transcriptomes across 16 cancer types, uncovering previously undescribed T cell states and heterogeneous subpopulations of follicular helper, regulatory and proliferative T cells. We identified a unique stress response state, T, characterized by heat shock gene expression. T cells are detectable in situ in the tumor microenvironment across various cancer types, mostly within lymphocyte aggregates or potential tertiary lymphoid structures in tumor beds or surrounding tumor edges. T cell states/compositions correlated with genomic, pathological and clinical features in 375 patients from 23 cohorts, including 171 patients who received immune checkpoint blockade therapy. We also found significantly upregulated heat shock gene expression in intratumoral CD4/CD8 cells following immune checkpoint blockade treatment, particularly in nonresponsive tumors, suggesting a potential role of T cells in immunotherapy resistance. Our well-annotated T cell reference maps, web portal and automatic alignment/annotation tool could provide valuable resources for T cell therapy optimization and biomarker discovery.

摘要

肿瘤浸润 T 细胞为癌症治疗提供了一个有前途的途径,但它们的状态仍有待充分描述。在这里,我们呈现了来自 16 种癌症类型的 308048 个转录组的 T 细胞单细胞图谱,揭示了以前未描述的 T 细胞状态和滤泡辅助、调节和增殖 T 细胞的异质性亚群。我们鉴定了一种独特的应激反应状态 T,其特征是热休克基因表达。T 细胞在各种癌症类型的肿瘤微环境中可在原位检测到,主要存在于淋巴细胞聚集物或肿瘤床或周围肿瘤边缘的潜在三级淋巴样结构内。T 细胞状态/组成与来自 23 个队列的 375 名患者的基因组、病理和临床特征相关,包括 171 名接受免疫检查点阻断治疗的患者。我们还发现,在免疫检查点阻断治疗后,肿瘤内 CD4/CD8 细胞中的热休克基因表达显著上调,特别是在无反应性肿瘤中,这表明 T 细胞在免疫治疗耐药性中可能发挥作用。我们的注释良好的 T 细胞参考图谱、网络门户和自动对齐/注释工具可以为 T 细胞治疗优化和生物标志物发现提供有价值的资源。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d1f/11421770/9a27e384e12e/nihms-2010124-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d1f/11421770/9bb4b216adaa/nihms-2010124-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d1f/11421770/21f06f23a7c4/nihms-2010124-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d1f/11421770/017daf3e6d12/nihms-2010124-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d1f/11421770/a5d7a17636e7/nihms-2010124-f0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d1f/11421770/34982bba0814/nihms-2010124-f0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d1f/11421770/3da09871f6a9/nihms-2010124-f0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d1f/11421770/943582ff9dba/nihms-2010124-f0013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d1f/11421770/c14580834c05/nihms-2010124-f0014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d1f/11421770/4d02a39dea4c/nihms-2010124-f0015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d1f/11421770/0f0bdb90324c/nihms-2010124-f0016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d1f/11421770/62e773f0c0f5/nihms-2010124-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d1f/11421770/45af3624a992/nihms-2010124-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d1f/11421770/0ee297fa879a/nihms-2010124-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d1f/11421770/3f5562235dac/nihms-2010124-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d1f/11421770/82d459558c68/nihms-2010124-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d1f/11421770/9a27e384e12e/nihms-2010124-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d1f/11421770/9bb4b216adaa/nihms-2010124-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d1f/11421770/21f06f23a7c4/nihms-2010124-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d1f/11421770/017daf3e6d12/nihms-2010124-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d1f/11421770/a5d7a17636e7/nihms-2010124-f0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d1f/11421770/34982bba0814/nihms-2010124-f0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d1f/11421770/3da09871f6a9/nihms-2010124-f0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d1f/11421770/943582ff9dba/nihms-2010124-f0013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d1f/11421770/c14580834c05/nihms-2010124-f0014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d1f/11421770/4d02a39dea4c/nihms-2010124-f0015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d1f/11421770/0f0bdb90324c/nihms-2010124-f0016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d1f/11421770/62e773f0c0f5/nihms-2010124-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d1f/11421770/45af3624a992/nihms-2010124-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d1f/11421770/0ee297fa879a/nihms-2010124-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d1f/11421770/3f5562235dac/nihms-2010124-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d1f/11421770/82d459558c68/nihms-2010124-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d1f/11421770/9a27e384e12e/nihms-2010124-f0006.jpg

相似文献

1
Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance.泛癌 T 细胞图谱将细胞应激反应状态与免疫治疗耐药性联系起来。
Nat Med. 2023 Jun;29(6):1550-1562. doi: 10.1038/s41591-023-02371-y. Epub 2023 May 29.
2
Evaluating the immunologically "cold" tumor microenvironment after treatment with immune checkpoint inhibitors utilizing PET imaging of CD4 + and CD8 + T cells in breast cancer mouse models.利用 PET 成像评估乳腺癌小鼠模型中免疫检查点抑制剂治疗后 CD4+和 CD8+T 细胞的免疫“冷”肿瘤微环境。
Breast Cancer Res. 2024 Jun 25;26(1):104. doi: 10.1186/s13058-024-01844-3.
3
Tertiary Lymphoid Structure-Associated B Cells Enhance CXCL13CD103CD8 Tissue-Resident Memory T-Cell Response to Programmed Cell Death Protein 1 Blockade in Cancer Immunotherapy.三级淋巴结构相关 B 细胞增强了趋化因子 CXCL13+CD103+CD8+组织驻留记忆 T 细胞对癌症免疫治疗中程序性细胞死亡蛋白 1 阻断的反应。
Gastroenterology. 2024 Jun;166(6):1069-1084. doi: 10.1053/j.gastro.2023.10.022. Epub 2023 Oct 29.
4
Tumor-infiltrating lymphocytes in the immunotherapy era.免疫治疗时代的肿瘤浸润淋巴细胞。
Cell Mol Immunol. 2021 Apr;18(4):842-859. doi: 10.1038/s41423-020-00565-9. Epub 2020 Nov 2.
5
Tumor cell-intrinsic SETD2 inactivation sensitizes cancer cells to immune checkpoint blockade through the NR2F1-STAT1 pathway.肿瘤细胞内在的 SETD2 失活通过 NR2F1-STAT1 通路使癌细胞对免疫检查点阻断敏感。
J Immunother Cancer. 2023 Dec 6;11(12):e007678. doi: 10.1136/jitc-2023-007678.
6
CXCL13 shapes immunoactive tumor microenvironment and enhances the efficacy of PD-1 checkpoint blockade in high-grade serous ovarian cancer.CXCL13 塑造免疫活性肿瘤微环境,并增强 PD-1 检查点阻断在高级别浆液性卵巢癌中的疗效。
J Immunother Cancer. 2021 Jan;9(1). doi: 10.1136/jitc-2020-001136.
7
Intratumoral CXCL13CD8T cell infiltration determines poor clinical outcomes and immunoevasive contexture in patients with clear cell renal cell carcinoma.肿瘤内 CXCL13CD8T 细胞浸润决定了透明细胞肾细胞癌患者的不良临床结局和免疫逃避结构。
J Immunother Cancer. 2021 Feb;9(2). doi: 10.1136/jitc-2020-001823.
8
Remodeling of the tumor microenvironment via disrupting Blimp1 effector Treg activity augments response to anti-PD-1 blockade.通过破坏 Blimp1 效应性 Treg 活性重塑肿瘤微环境可增强对抗 PD-1 封锁的反应。
Mol Cancer. 2021 Nov 20;20(1):150. doi: 10.1186/s12943-021-01450-3.
9
Oncolytic adenovirus decreases the proportion of TIM-3 subset of tumor-infiltrating CD8 T cells with correlation to improved survival in patients with cancer.溶瘤腺病毒降低了肿瘤浸润性 CD8 T 细胞中 TIM-3 亚群的比例,与癌症患者的生存改善相关。
J Immunother Cancer. 2022 Feb;10(2). doi: 10.1136/jitc-2021-003490.
10
Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.基质 PD-L1 阳性调节性 T 细胞和 PD-1 阳性 CD8 阳性 T 细胞定义了不同亚组非小细胞肺癌对 PD-1/PD-L1 阻断免疫治疗的反应。
J Thorac Oncol. 2018 Apr;13(4):521-532. doi: 10.1016/j.jtho.2017.11.132. Epub 2017 Dec 18.

引用本文的文献

1
HOMER3 orchestrates SRC-YAP1 activity that promotes tumor cell growth and antagonizes anti-tumor immunotherapy in prostate cancer.HOMER3 协调 SRC-YAP1 活性,促进肿瘤细胞生长并拮抗前列腺癌中的抗肿瘤免疫治疗。
Oncogene. 2025 Aug 23. doi: 10.1038/s41388-025-03548-0.
2
Integrative single-cell transcriptomic analysis deciphers heterogeneous characteristics of gastrointestinal tract cancer.整合单细胞转录组分析揭示胃肠道癌的异质性特征。
Clin Transl Med. 2025 Aug;15(8):e70415. doi: 10.1002/ctm2.70415.
3
Machine learning-driven multi-omics analysis identifies a prognostic gene signature associated with programmed cell death and metabolism in hepatocellular carcinoma.

本文引用的文献

1
Deciphering tumor ecosystems at super resolution from spatial transcriptomics with TESLA.利用 TESLA 技术从空间转录组学中对肿瘤生态系统进行超高分辨率解析。
Cell Syst. 2023 May 17;14(5):404-417.e4. doi: 10.1016/j.cels.2023.03.008. Epub 2023 May 9.
2
High-plex imaging of RNA and proteins at subcellular resolution in fixed tissue by spatial molecular imaging.通过空间分子成像在固定组织中以亚细胞分辨率对RNA和蛋白质进行高多重成像。
Nat Biotechnol. 2022 Dec;40(12):1794-1806. doi: 10.1038/s41587-022-01483-z. Epub 2022 Oct 6.
3
Single-cell meta-analyses reveal responses of tumor-reactive CXCL13 T cells to immune-checkpoint blockade.
机器学习驱动的多组学分析鉴定出与肝细胞癌程序性细胞死亡和代谢相关的预后基因特征。
Biol Proced Online. 2025 Aug 9;27(1):29. doi: 10.1186/s12575-025-00286-1.
4
Pan-cancer single cell transcriptomic clustering reveals heterogeneous CD8 exhausted T cell populations with different immune checkpoint inhibitor responses.泛癌单细胞转录组聚类揭示了具有不同免疫检查点抑制剂反应的异质性耗竭CD8 T细胞群体。
Oncoimmunology. 2025 Dec;14(1):2540504. doi: 10.1080/2162402X.2025.2540504. Epub 2025 Aug 3.
5
Identification of a stromal immunosuppressive barrier orchestrated by SPP1/C1QC macrophages and CD8 exhausted T cells driving gastric cancer immunotherapy resistance.鉴定由SPP1/C1QC巨噬细胞和CD8耗竭性T细胞共同构成的基质免疫抑制屏障,其驱动胃癌免疫治疗耐药性。
Front Immunol. 2025 Jul 16;16:1618591. doi: 10.3389/fimmu.2025.1618591. eCollection 2025.
6
Immune cell landscape in a human decedent receiving a pig liver xenograft.接受猪肝异种移植的人类死者体内的免疫细胞图谱。
Nat Med. 2025 Jul 30. doi: 10.1038/s41591-025-03860-y.
7
LARP4-mediated hypertranslation drives T cell dysfunction in tumors.LARP4介导的超翻译驱动肿瘤中的T细胞功能障碍。
Nat Immunol. 2025 Jul 22. doi: 10.1038/s41590-025-02232-5.
8
Integration of single cell and bulk transcriptomes identifies T cell stress subtypes in LUAD.单细胞转录组与整体转录组的整合鉴定了肺腺癌中的T细胞应激亚型。
Discov Oncol. 2025 Jul 17;16(1):1360. doi: 10.1007/s12672-025-03170-2.
9
Multi-omics analysis reveals glutathione metabolism-related immune suppression and constructs a prognostic model in lung adenocarcinoma.多组学分析揭示了与谷胱甘肽代谢相关的免疫抑制作用,并构建了肺腺癌的预后模型。
Front Immunol. 2025 Jul 2;16:1608407. doi: 10.3389/fimmu.2025.1608407. eCollection 2025.
10
Deciphering cancer therapy resistance via patient-level single-cell transcriptomics with CellResDB.通过使用CellResDB的患者水平单细胞转录组学来解读癌症治疗耐药性。
Commun Biol. 2025 Jul 15;8(1):1049. doi: 10.1038/s42003-025-08457-2.
单细胞荟萃分析揭示肿瘤反应性 CXCL13 T 细胞对免疫检查点阻断的反应。
Nat Cancer. 2022 Sep;3(9):1123-1136. doi: 10.1038/s43018-022-00433-7. Epub 2022 Sep 22.
4
Spatial transcriptomics.空间转录组学。
Cancer Cell. 2022 Sep 12;40(9):895-900. doi: 10.1016/j.ccell.2022.08.021.
5
The Single-Cell Immunogenomic Landscape of B and Plasma Cells in Early-Stage Lung Adenocarcinoma.早期肺腺癌中 B 细胞和浆细胞的单细胞免疫基因组图谱。
Cancer Discov. 2022 Nov 2;12(11):2626-2645. doi: 10.1158/2159-8290.CD-21-1658.
6
Follicular Lymphoma Microenvironment Characteristics Associated with Tumor Cell Mutations and MHC Class II Expression.滤泡性淋巴瘤微环境特征与肿瘤细胞突变和 MHC Ⅱ类表达相关。
Blood Cancer Discov. 2022 Sep 6;3(5):428-443. doi: 10.1158/2643-3230.BCD-21-0075.
7
Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer.三级淋巴结构在肾细胞癌中生成并扩增产生抗肿瘤抗体的浆细胞。
Immunity. 2022 Mar 8;55(3):527-541.e5. doi: 10.1016/j.immuni.2022.02.001. Epub 2022 Feb 28.
8
Temporal single-cell tracing reveals clonal revival and expansion of precursor exhausted T cells during anti-PD-1 therapy in lung cancer.时间分辨单细胞追踪揭示了抗 PD-1 治疗肺癌过程中耗竭前体细胞 T 细胞的克隆复兴和扩增。
Nat Cancer. 2022 Jan;3(1):108-121. doi: 10.1038/s43018-021-00292-8. Epub 2021 Dec 23.
9
Pan-cancer single-cell landscape of tumor-infiltrating T cells.泛癌种肿瘤浸润 T 细胞单细胞全景分析。
Science. 2021 Dec 17;374(6574):abe6474. doi: 10.1126/science.abe6474.
10
Single cell T cell landscape and T cell receptor repertoire profiling of AML in context of PD-1 blockade therapy.在 PD-1 阻断治疗背景下,对 AML 的单细胞 T 细胞景观和 T 细胞受体库进行分析。
Nat Commun. 2021 Oct 18;12(1):6071. doi: 10.1038/s41467-021-26282-z.